Widespread lymph node recurrence of major duodenal papilla cancer following pancreaticoduodenectomy

World J Gastroenterol. 2015 Dec 28;21(48):13593-8. doi: 10.3748/wjg.v21.i48.13593.

Abstract

Major duodenal papilla cancer (MDPC) represents the primary type of duodenal cancer, and is typically considered a periampullary carcinoma as most tumors arise in this region. This report describes an extremely rare case involving a patient with rapidly and extensively recurrent MDPC following pancreaticoduodenectomy, who achieved complete response by concurrent image-guided radiation and intravenous oxaliplatin plus oral capecitabine therapies. The patient was a 50-year-old female who was admitted to our hospital 6 wk after resection for MDPC for evaluation of a nontender and enlarged node in the left side of her neck. After clinical work-up, the patient was diagnosed with postoperatively recurrent MDPC with widespread lymph node metastases at the bilateral cervix, mediastinum, abdominal cavity, and retroperitoneal area. She was administered whole field image-guided radiation therapy along with four cycles of the intravenous oxaliplatin plus oral capecitabine regimen. A complete response by positron emission tomography with 18-fluorodeoxyglucose was observed 4 months after treatment. The patient continues to be disease-free 2 years after the diagnosis of recurrence.

Keywords: Chemoradiotherapy; Complete response; Neoplasm recurrence; Pancreaticoduodenectomy; Periampullary cancer.

Publication types

  • Case Reports
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Ampulla of Vater / pathology
  • Ampulla of Vater / surgery*
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use
  • Capecitabine / administration & dosage
  • Chemoradiotherapy
  • Common Bile Duct Neoplasms / pathology
  • Common Bile Duct Neoplasms / surgery*
  • Female
  • Fluorodeoxyglucose F18
  • Humans
  • Lymphatic Metastasis
  • Middle Aged
  • Multimodal Imaging / methods
  • Organoplatinum Compounds / administration & dosage
  • Oxaliplatin
  • Pancreaticoduodenectomy*
  • Positron-Emission Tomography
  • Radiopharmaceuticals
  • Remission Induction
  • Time Factors
  • Tomography, X-Ray Computed
  • Treatment Outcome

Substances

  • Organoplatinum Compounds
  • Radiopharmaceuticals
  • Oxaliplatin
  • Fluorodeoxyglucose F18
  • Capecitabine